An objective evaluation of haloperidol in Gilles de la Tourette's syndrome.
D000328:Adult; D002986:Clinical Trials as Topic; D005260:Female; D006220:Haloperidol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D013375:Substance Withdrawal Syndrome; D013997:Time Factors; D005879:Tourette Syndrome / Q000175:diagnosis / Q000188:drug therapy*
D010919:Placebos; D006220:Haloperidol